ClearPoint Neuro, Inc.
CLPT
$12.56
-$0.62-4.70%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.77M | 8.12M | 7.86M | 7.64M | 6.81M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.77M | 8.12M | 7.86M | 7.64M | 6.81M |
| Cost of Revenue | 3.01M | 3.28M | 2.87M | 3.11M | 2.80M |
| Gross Profit | 4.76M | 4.85M | 4.99M | 4.53M | 4.01M |
| SG&A Expenses | 7.03M | 6.70M | 6.61M | 6.13M | 6.07M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.38M | 13.29M | 12.60M | 11.87M | 11.52M |
| Operating Income | -5.60M | -5.17M | -4.74M | -4.23M | -4.71M |
| Income Before Tax | -5.39M | -4.97M | -4.41M | -4.15M | -4.62M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.39M | -4.97M | -4.41M | -4.15M | -4.62M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.39M | -4.97M | -4.41M | -4.15M | -4.62M |
| EBIT | -5.60M | -5.17M | -4.74M | -4.23M | -4.71M |
| EBITDA | -5.36M | -4.91M | -4.51M | -3.99M | -4.52M |
| EPS Basic | -0.20 | -0.18 | -0.16 | -0.16 | -0.19 |
| Normalized Basic EPS | -0.12 | -0.11 | -0.10 | -0.10 | -0.12 |
| EPS Diluted | -0.20 | -0.18 | -0.16 | -0.16 | -0.19 |
| Normalized Diluted EPS | -0.12 | -0.11 | -0.10 | -0.10 | -0.12 |
| Average Basic Shares Outstanding | 27.59M | 27.59M | 27.47M | 25.45M | 24.62M |
| Average Diluted Shares Outstanding | 27.59M | 27.59M | 27.47M | 25.45M | 24.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
